Close Menu

NEW YORK (GenomeWeb) – Applied BioCode has submitted a high-volume molecular testing platform and a gastrointestinal panel to the US Food and Drug Administration for 510(k) clearance following recently completed clinical trials, the company announced today.

The firm intends its BioCode MDx-3000 automated PCR-based molecular diagnostic testing system to be used in large hospitals and reference labs.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

May
22

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.